Onderneming CytRx Corporation Other OTC
Aandelen
CYTR
US2328286081
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Snowdy
CEO | Chief Executive Officer | 55 | 10-01-22 |
John Caloz
DFI | Director of Finance/CFO | 72 | 01-10-07 |
Cristina Newman
SEC | Corporate Secretary | - | - |
Felix Kratz
PRN | Corporate Officer/Principal | - | 17-03-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jennifer Simpson
CHM | Chairman | 55 | 29-07-21 |
Cary Claiborne
BRD | Director/Board Member | 64 | 27-07-22 |
Joel Caldwell
BRD | Director/Board Member | 69 | 12-07-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 495 092 | 492 306 ( 99,44 %) | 0 | 99,44 % |
Bedrijfsgegevens
LadRx Corp.
11726 San Vicente Boulevard Suite 650
90049, Los Angeles
+310 826 5648
http://www.ladrxcorp.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,50% | 49,18 mld. | |
+0,80% | 42,11 mld. | |
+50,47% | 40,37 mld. | |
-5,26% | 28,85 mld. | |
+13,73% | 26,09 mld. | |
-22,83% | 18,71 mld. | |
+8,21% | 13,26 mld. | |
+32,42% | 12,32 mld. | |
-1,28% | 11,99 mld. |